ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
07-Apr-2008 -
Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced the completion of the sale of ActivBiotics intellectual property assets for $3.5 million. The assets consisted of 1) Rifalazil, a Phase II antibiotic, 2) a library of novel rifamycin compounds, and 3) a ...
superoxide dismutase